• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病中符号数字模态测验得分极端值的识别。

Identification of symbol digit modality test score extremes in Huntington's disease.

机构信息

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

Department of Neurology, Ulm University, Ulm, Germany.

出版信息

Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):232-245. doi: 10.1002/ajmg.b.32719. Epub 2019 Feb 20.

DOI:10.1002/ajmg.b.32719
PMID:30788902
Abstract

Studying individuals with extreme phenotypes could facilitate the understanding of disease modification by genetic or environmental factors. Our aim was to identify Huntington's disease (HD) patients with extreme symbol digit modality test (SDMT) scores. We first examined in HD the contribution of cognitive measures of the Unified Huntington's Disease Rating Scale (UHDRS) in predicting clinical endpoints. The language-independent SDMT was used to identify patients performing very well or very poorly relative to their CAG and age cohort. We used data from REGISTRY and COHORT observational study participants (5,603 HD participants with CAG repeats above 39 with 13,868 visits) and of 1,006 healthy volunteers (with 2,241 visits), included to identify natural aging and education effects on cognitive measures. Separate Cox proportional hazards models with CAG, age at study entry, education, sex, UHDRS total motor score and cognitive (SDMT, verbal fluency, Stroop tests) scores as covariates were used to predict clinical endpoints. Quantile regression for longitudinal language-independent SDMT data was used for boundary (2.5% and 97.5% quantiles) estimation and extreme score analyses stratified by age, education, and CAG repeat length. Ten percent of HD participants had an extreme SDMT phenotype for at least one visit. In contrast, only about 3% of participants were consistent SDMT extremes at two or more visits. The thresholds for the one-visit and two-visit extremes can be used to classify existing and new individuals. The identification of these phenotype extremes can be useful in the search for disease modifiers.

摘要

研究具有极端表型的个体可以帮助我们理解遗传或环境因素对疾病的影响。我们的目的是确定亨廷顿病(HD)患者中具有极端符号数字模态测试(SDMT)评分的个体。我们首先在 HD 中检查了统一亨廷顿病评定量表(UHDRS)认知测量对预测临床终点的贡献。使用独立于语言的 SDMT 来识别相对于其 CAG 和年龄队列表现非常好或非常差的患者。我们使用 REGISTRY 和 COHORT 观察性研究参与者的数据(5603 名 CAG 重复次数大于 39 的 HD 参与者,有 13868 次就诊)和 1006 名健康志愿者的数据(有 2241 次就诊),以确定自然衰老和教育对认知测量的影响。使用 Cox 比例风险模型,将 CAG、研究开始时的年龄、教育、性别、UHDRS 总运动评分和认知(SDMT、语言流畅性、Stroop 测试)评分作为协变量,以预测临床终点。使用纵向独立语言的 SDMT 数据的分位数回归进行边界(2.5%和 97.5%分位数)估计和极端评分分析,按年龄、教育和 CAG 重复长度分层。10%的 HD 参与者在至少一次就诊时表现出极端 SDMT 表型。相比之下,只有约 3%的参与者在两次或更多次就诊时表现出一致的 SDMT 极端情况。单次就诊和两次就诊极端值的阈值可用于对现有和新个体进行分类。这些表型极端值的识别在寻找疾病修饰因子方面可能很有用。

相似文献

1
Identification of symbol digit modality test score extremes in Huntington's disease.亨廷顿病中符号数字模态测验得分极端值的识别。
Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):232-245. doi: 10.1002/ajmg.b.32719. Epub 2019 Feb 20.
2
Cognitive and Motor Norms for Huntington's Disease.亨廷顿病的认知和运动标准。
Arch Clin Neuropsychol. 2020 Aug 28;35(6):671-682. doi: 10.1093/arclin/acaa026.
3
Identification of extreme motor phenotypes in Huntington's disease.亨廷顿舞蹈病极端运动表型的鉴定。
Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):283-294. doi: 10.1002/ajmg.b.32514. Epub 2016 Nov 21.
4
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.TRACK-HD 研究中在无症状和早期亨廷顿病中表型进展和疾病发作的预测因素:36 个月观察性数据的分析。
Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.
5
Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.认知功能障碍导致亨廷顿舞蹈症患者行动能力受损。
J Huntingtons Dis. 2017;6(4):363-370. doi: 10.3233/JHD-170279.
6
Modeling Disease Progression and Placebo Response in Huntington Disease: Insights From Enroll-HD and GENERATION HD1 Cohorts.亨廷顿病中疾病进展和安慰剂反应的建模:来自Enroll-HD和GENERATION HD1队列的见解
Neurology. 2025 May 27;104(10):e213646. doi: 10.1212/WNL.0000000000213646. Epub 2025 May 2.
7
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.鉴定与亨廷顿病进展相关的遗传变异:全基因组关联研究。
Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.
8
Assessing Decline: Visualising Progression in Huntington's Disease using a Clinical Dashboard with Enroll-HD Data.评估衰退:使用包含“注册入组亨廷顿病研究(Enroll-HD)”数据的临床仪表板可视化亨廷顿病的进展情况。
J Huntingtons Dis. 2017;6(2):139-147. doi: 10.3233/JHD-170234.
9
Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study.影响中国亨廷顿病患者认知功能的因素:一项横断面临床研究。
Brain Behav. 2023 Nov;13(11):e3258. doi: 10.1002/brb3.3258. Epub 2023 Oct 17.
10
The Effect of Education on Symptom Onset and Severity of Huntington's Disease.教育对亨廷顿舞蹈症症状发作及严重程度的影响。
Mov Disord Clin Pract. 2021 Mar 30;8(4):555-562. doi: 10.1002/mdc3.13195. eCollection 2021 May.

引用本文的文献

1
Specific contribution of cognitive and motor impairments with functional capacity and dependence in Huntington's disease.认知和运动障碍对亨廷顿病功能能力和依赖程度的具体影响。
J Neurol. 2025 Feb 22;272(3):224. doi: 10.1007/s00415-025-12982-9.
2
Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease.血浆细胞外囊泡中的小分子 RNA 定义亨廷顿病前变化的生物标志物。
J Extracell Vesicles. 2024 Oct;13(10):e12522. doi: 10.1002/jev2.12522.
3
Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease.
与亨廷顿病中的 Tau 相关的认知表型和神经退行性变。
Ann Clin Transl Neurol. 2024 May;11(5):1160-1171. doi: 10.1002/acn3.52031. Epub 2024 Mar 27.
4
Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study.多发性硬化背景下认知加工速度(CPS)受损的负效用:一项时间权衡(TTO)诱导研究。
Clinicoecon Outcomes Res. 2024 Feb 8;16:55-67. doi: 10.2147/CEOR.S433294. eCollection 2024.
5
Prodromal Cognitive Changes as a Prognostic Indicator of Forthcoming Huntington's Disease Severity: A Retrospective Longitudinal Study.前驱认知变化作为即将发生的亨廷顿病严重程度的预后指标:一项回顾性纵向研究。
Mov Disord Clin Pract. 2024 Apr;11(4):363-372. doi: 10.1002/mdc3.13975. Epub 2024 Jan 24.
6
Genetic modifiers of Huntington disease differentially influence motor and cognitive domains.亨廷顿病的遗传修饰物对运动和认知领域有不同的影响。
Am J Hum Genet. 2022 May 5;109(5):885-899. doi: 10.1016/j.ajhg.2022.03.004. Epub 2022 Mar 23.
7
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.扩充亨廷顿病治疗武器库——草药药物及其纳米制剂。
Curr Neuropharmacol. 2021;19(7):957-989. doi: 10.2174/1570159X18666201109090824.
8
Structural brain correlates of dementia in Huntington's disease.亨廷顿病痴呆的结构脑相关性。
Neuroimage Clin. 2020;28:102415. doi: 10.1016/j.nicl.2020.102415. Epub 2020 Sep 9.